content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <!-- Generated by Workiva -->
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001738054</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001723128</issuerCik>
        <issuerName>Amneal Pharmaceuticals Inc.</issuerName>
        <secFileNumber>001-38485</secFileNumber>
        <issuerAddress>
          <com:street1>9880 CAMPUS POINT DRIVE SUITE 120</com:street1>
          <com:city>San Diego</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92121</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>908-947-3146</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Gautam J Patel</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Director</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>J.P. Morgan Securities LLC</name>
          <address>
            <com:street1>390 Madison Avenue</com:street1>
            <com:street2>6th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>320000</noOfUnitsSold>
        <aggregateMarketValue>2560000</aggregateMarketValue>
        <noOfUnitsOutstanding>309844430</noOfUnitsOutstanding>
        <approxSaleDate>01/02/2025</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>01/01/2024</acquiredDate>
        <natureOfAcquisitionTransaction>Distribution from Trust - the AHPPCB Legacy Trust dated Februay 1, 2014</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>See Nature of Acquisition</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>320000</amountOfSecuritiesAcquired>
        <paymentDate>05/04/2018</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>01/02/2025</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>08/15/2024</planAdoptionDate>
        </planAdoptionDates>
        <signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Gautam J Patel.</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3050}]
text: 144
  0001738054
  XXXXXXXX
  LIVE
  0001723128
  Amneal Pharmaceuticals Inc.
  001-38485
  9880 CAMPUS POINT DRIVE SUITE 120
  San Diego
  CA
  92121
  908-947-3146
  Gautam J Patel
  Director
  Common
  J.P. Morgan Securities LLC
  390 Madison Avenue
  6th Floor
  New York
  NY
  10017
  320000
  2560000
  309844430
  01/02/2025
  NASDAQ
  Common
  01/01/2024
  Distribution from Trust - the AHPPCB Legacy Trust dated Februay 1, 2014
  See Nature of Acquisition
  N
  320000
  05/04/2018
  Cash
  Y
  01/02/2025
  08/15/2024
  /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Gautam J Patel.